AdvaGen Pharma
Jonathon Hurley is a seasoned professional in the pharmaceutical industry with a strong background in pricing analysis and account management. Currently serving as the National Account Manager at AdvaGen Pharma, Jonathon previously excelled as a Senior Pricing Analyst at Granules Pharmaceuticals, Inc., where notable achievements included leading pricing activities that resulted in a 151% increase in revenues and margins over two years. Prior roles include Institutional Business Analyst and Associate Pricing Analyst at Amneal Pharmaceuticals, where Jonathon formulated analytical plans and developed reporting tools. Jonathon began a career at Johnson & Johnson as a Financial Analyst, contributing to sales evaluations and supporting the Field Sales organization. Jonathon holds a Bachelor's degree in Business Administration and Management from the University of Delaware.
This person is not in any teams
AdvaGen Pharma
AdvaGen Pharma is an integrated specialty pharmaceutical company, focused on providing innovative solutions for patients, customers, and partners by developing, manufacturing, and marketing high quality prescription branded and generic pharmaceutical products. It is poised for growth by introducing value-added pharmaceuticals across the oral solids, oral liquids, topicals, injectables, and nasal spray dosage forms, as well as niche, high barrier opportunities across medical devices and drug-device combinations. AdvaGen Pharma sources its products from its parent organization, Rubicon Research Pvt Ltd, as well as from a network of high quality, US FDA inspected manufacturing facilities across the globe. AdvaGen’s strong focus on reliable supplies is backed by own manufacturing across oral solid and liquid products and upcoming expansion of sites to also include complex dosage forms like sterile and drug device products. AdvaGen will continue to source over 70% of its products by in-house manufacturing through its rapid expansion portfolio expansion. The name AdvaGen is a combination of the words ‘ADVAnced GENerics’ and we believe that we are firmly on our way to establishing our mission through our rapidly expanding product portfolio, innovations that fulfil unmet medical needs, and by enabling smarter health care delivery.